ARM is the global voice of the cell and gene therapy sector, representing more than 400 members across 25 countries, including emerging and established biotechnology companies, academic …

5 days ago · Dr. Peter Marks has been a visionary leader, advocate for rare disease patients, and champion of cell and gene therapy (CGT) during his nine-year tenure as the Director of FDA’s …

Jan 8, 2024 · ARM gathering of sector leaders mapping the future of cell and gene therapy Identify emerging technologies in the sector that are most likely to require novel solutions for …

Cell therapy is the administration of viable, often purified cells into a patient’s body to grow, replace, or repair damaged tissue for the treatment of a disease.

The Alliance for Regenerative Medicine will be hosting a six-part webinar series that will highlight A-Gene, a case study based approach to integrating QbD principles in Gene Therapy CMC …

Learn more about the Alliance for Regenerative Medicine (ARM)'s annual events. ARM’s meetings bring together industry leaders, investors, policy makers, clinicians and patients to …

Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale …

The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, …

Jul 26, 2022 · ARM promotes legislative, regulatory, reimbursement and manufacturing initiatives to advance this innovative and transformative sector, which includes cell therapies, gene …

Oct 31, 2019 · The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader advanced therapies sector, …